Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 
Open AccessResearch

Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success

Glen J Mcintyre1 email, Yi-Hsin Yu1 email, Anna Tran1 email, Angel B Jaramillo1 email, Allison J Arndt1 email, Michelle L Millington1 email, Maureen P Boyd1 email, Fiona A Elliott1 email, Sylvie W Shen1 email, John M Murray2,3 email and Tanya L Applegate1 email

Johnson and Johnson Research Pty Ltd, Level 4 Biomedical Building, 1 Central Avenue, Australian Technology Park, Eveleigh, NSW, 1430, Australia

School of Mathematics and Statistics, The University of New South Wales, Sydney, NSW, 2052, Australia

The National Center in HIV Epidemiology and Clinical Research, The University of New South Wales, 376 Victoria St. Darlinghurst, NSW, 2010, Australia

author email corresponding author email

Virology Journal 2009, 6:184doi:10.1186/1743-422X-6-184

Published: 30 October 2009

Abstract

Background

Multiple short hairpin RNA (shRNA) gene therapy strategies are currently being investigated for treating viral diseases such as HIV-1. It is important to use several different shRNAs to prevent the emergence of treatment-resistant strains. However, there is evidence that repeated expression cassettes delivered via lentiviral vectors may be subject to recombination-mediated repeat deletion of 1 or more cassettes.

Results

The aim of this study was to determine the frequency of deletion for 2 to 6 repeated shRNA cassettes and mathematically model the outcomes of different frequencies of deletion in gene therapy scenarios. We created 500+ clonal cell lines and found deletion frequencies ranging from 2 to 36% for most combinations. While the central positions were the most frequently deleted, there was no obvious correlation between the frequency or extent of deletion and the number of cassettes per combination. We modeled the progression of infection using combinations of 6 shRNAs with varying degrees of deletion. Our in silico modeling indicated that if at least half of the transduced cells retained 4 or more shRNAs, the percentage of cells harboring multiple-shRNA resistant viral strains could be suppressed to < 0.1% after 13 years. This scenario afforded a similar protection to all transduced cells containing the full complement of 6 shRNAs.

Conclusion

Deletion of repeated expression cassettes within lentiviral vectors of up to 6 shRNAs can be significant. However, our modeling showed that the deletion frequencies observed here for 6× shRNA combinations was low enough that the in vivo suppression of replication and escape mutants will likely still be effective.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.